SCHEMBL276428

SCHEMBL276428

CCC(C)C(C)C([NH])=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8848202 0.79 METAP1 (0.40)
SCHEMBL11559829 0.77 TSHR (0.37)
SCHEMBL276399 0.74
SCHEMBL4572067 0.74
SCHEMBL16317747 0.74
SCHEMBL24827776 0.74
SCHEMBL6113197 0.74
SCHEMBL1785218 0.74
SCHEMBL14092746 0.74
SCHEMBL5371229 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0143001-B1 PYRIMIDOISOQUINOLINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-04-10 EP claimed
US-4673676-A Pyrimidoisoquinoline derivatives useful for treating allergies FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-16 US claimed
EP-0143001-A2 Pyrimidoisoquinoline derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-05-29 EP claimed
US-20230094952-A1 Method for Culturing Hematopoietic Stem Cells Sumitomo Pharma Co., Ltd. (JP) 2023-03-30 US disclosed
EP-4071239-A1 METHOD FOR CULTURING HEMATOPOIETIC STEM CELLS Sumitomo Pharma Co., Ltd. (JP) 2022-10-12 EP disclosed
CN-114901810-A Method for culturing hematopoietic stem cells 住友制药株式会社 2022-08-12 CN disclosed
WO-2021132627-A1 METHOD FOR CULTURING HEMATOPOIETIC STEM CELLS 大日本住友製薬株式会社 2021-07-01 WO disclosed
US-9543147-B2 Photoresist and method of manufacture TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2017-01-10 US disclosed
EP-2439204-B1 HETEROCYCLIC COMPOUND AND HEMATOPOIETIC STEM CELL AMPLIFIER NISSAN CHEMICAL IND LTD (JP) 2017-01-04 EP disclosed
US-9527828-B2 Method for expanding hematopoietic stem cells using heterocyclic compound NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-12-27 US disclosed
US-9502231-B2 Photoresist layer and method TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2016-11-22 US disclosed
EP-0668852-A1 SUBSTITUTED ORTHO-ETHENYL-PHENYL ACETIC ACID DERIVATIVES BASF Aktiengesellschaft (DE) 1995-08-30 EP disclosed
WO-1994019331-A1 ORTHO-SUBSTITUTED 2-METHOXYIMINOPHENYLACETIC ACID METHYLAMIDES BASF AKTIENGESELLSCHAFT (DE) 1994-09-01 WO disclosed
EP-0414058-B1 Carboxylic acid derivatives BASF AG (DE) 1994-06-15 EP disclosed
WO-1994011334-A1 SUBSTITUTED ORTHO-ETHENYL-PHENYL ACETIC ACID DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 1994-05-26 WO disclosed
US-5085685-A Herbicides BASF AKTIENGESELLSCHAFT (DE) 1992-02-04 US disclosed
EP-0414058-A2 Carboxylic acid derivatives BASF Aktiengesellschaft (DE) 1991-02-27 EP disclosed
US-4673676-A Pyrimidoisoquinoline derivatives useful for treating allergies FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-06-16 US disclosed
US-4618610-A Triazine derivatives, and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-10-21 US disclosed
EP-0123254-A1 Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 EP disclosed